Study of the 2.25mm Sirolimus-Eluting Stent in the Treatment of Patients With Coronary Artery Lesions

NCT00232739 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DEVICE: CYPHER Sirolimus-eluting Coronary Stent

Sponsor

Cordis US Corp.